Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation

Pharmaceutical Biology

Volumn 50, Issue 12, 2012, Pages 1531-1535

  Li, Daxin ^a   Mitsuhashi, Shinya ^a   Ubukata, Makoto ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Hesperetin enantiomers; Hesperidin epimers; Maillard reaction; Monoglucosyl hesperidin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE DERIVATIVE; ANTIDIABETIC AGENT; BOVINE SERUM ALBUMIN; DEXTRO MONOGLUCOSYL HESPERIDIN; GLUCOSYL HESPERIDIN; HESPERETIN; HESPERIDIN; HESPERIDIN DERIVATIVE; RIBONUCLEASE A METHYLGLYOXAL; UNCLASSIFIED DRUG;

AGING; ARTICLE; CHIRALITY; CHRONIC DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MIXTURE; DRUG SCREENING; DRUG STRUCTURE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INHIBITION KINETICS; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

GLUCOSE; GLUCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; HESPERIDIN; HIGH-THROUGHPUT SCREENING ASSAYS; HYPOGLYCEMIC AGENTS; MAILLARD REACTION; MOLECULAR STRUCTURE; PYRUVALDEHYDE; RIBONUCLEASE, PANCREATIC; SERUM ALBUMIN, BOVINE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

BOVINAE;

EID: 84869460448     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.694106     Document Type: Article

References (18)

1. Abdel-Rahman E, Bolton WK. (2002). Pimagedine: a novel therapy for diabetic nephropathy. Expert Opin Investig Drugs, 11, 565-574. (Pubitemid 34450126)
2. Ariëns EJ. (1984). Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol, 26, 663-668. (Pubitemid 14074636)
3. Belboukhari N, Cheriti A, Roussel C, Vanthuyne N. (2010). Chiral separation of hesperidin and naringin and its analysis in a butanol extract of Launeae arborescens. Nat Prod Res, 24, 669-681.
4. Bergmeyer HU. (1984). Methods of Enzymatic Analysis (Third ed.), New York, USA: Academic Press, 136-139.
5. Brand W, Shao J, Hoek-van den Hil EF, van Elk KN, Spenkelink B, de Haan LH, Rein MJ, Dionisi F, Williamson G, van Bladeren PJ, Rietjens IM. (2010). Stereoselective conjugation, transport and bioactivity of S-and R-hesperetin enantiomers in vitro. J Agric Food Chem, 58, 6119-6125.
6. Caccamese S, Caruso C, Parrinello N, Savarino A. (2005). Highperformance liquid chromatographic separation and chiroptical properties of the enantiomers of naringenin and other flavanones. J Chromatogr A, 1076, 155-162. (Pubitemid 40725189)
7. Fatima S, Jairajpuri DS, Saleemuddin M. (2008). A procedure for the rapid screening of Maillard reaction inhibitors. J Biochem Biophys Methods, 70, 958-965.
8. Horvat S, Jakas A. (2004). Peptide and amino acid glycation: New insights into the Maillard reaction. J Pept Sci, 10, 119-137. (Pubitemid 38477090)
9. Lv L, Shao X, Chen H, Ho CT, Sang S. (2011). Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem Res Toxicol, 24, 579-586.
10. Matsuda H, Wang T, Managi H, Yoshikawa M. (2003). Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem, 11, 5317-5323. (Pubitemid 37464658)
11. Matsuura N, Aradate T, Sasaki C, Kojima H, Ohara M, Hasegawa J, Ubukata M. (2002). Screening system for the Maillard reaction inhibitor from natural product extracts. J Health Sci, 48, 520-526. (Pubitemid 41301505)
12. Miyake Y, Yamamoto K, Tsujihara N, Osawa T. (1998). Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids, 33, 689-695. (Pubitemid 28328798)
13. Sasaki NA, Garcia-Alvarez MC, Wang Q, Ermolenko L, Franck G, Nhiri N, Martin MT, Audic N, Potier P. (2009). N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation. Bioorg Med Chem, 17, 2310-2320.
14. Spencer JPE. (2008). Flavonoids: Modulators of brain function? Br J Nutr, 99, ES60-ES77.
15. Thornalley PJ. (2005). Dicarbonyl intermediates in the Maillard reaction. Ann N Y Acad Sci, 1043, 111-117. (Pubitemid 41123896)
16. Thornalley PJ, Langborg A, Minhas HS. (1999). Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J, 344 Pt 1, 109-116.
17. Urios P, Grigorova-Borsos AM, Sternberg M. (2007). Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur J Nutr, 46, 139-146. (Pubitemid 46486620)
18. Vinson J, Howard T. (1996). Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem, 7, 659-663. (Pubitemid 27019421)